Market Tracker

03/26 5:45pm ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

32.94
Delayed Data
As of Mar 26
 -0.69 / -2.05%
Today’s Change
28.26
Today|||52-Week Range
45.45
-19.40%
Year-to-Date

Today’s Trading

Previous close33.63
Today’s open33.62
Day’s range32.39 - 33.99
Volume611,781
Average volume (3 months)769,017
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 03/26/2015

Growth & Valuation

Earnings growth (last year)+7.69%
Earnings growth (this year)-139.85%
Earnings growth (next 5 years)+15.50%
Revenue growth (last year)+19.34%
P/E ratio79.3
Price/Sales4.19
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CMRXChimerix Inc+1.03+2.90%
LGNDLigand Pharmaceutica...-0.40-0.57%
USNAUSANA Health Science...+0.01+0.01%
NLNKNewLink Genetics Cor...+1.57+3.32%
Data as of 4:02pm ET, 03/26/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$401.5M
Annual profit (last year)$17.7M
Net profit margin4.40%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts